Interaction of sulfonated anionic porphyrins with HIV glycoprotein gp120: Photodamages revealed by inhibition of antibody binding to V3 and C5 domains

Antiviral Research

Volumn 61, Issue 1, 2004, Pages 37-47

  Dairou, Julien ^a,b   Vever Bizet, Christine ^a,b   Brault, Daniel ^a,b  

^a CNRS   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Antibody; gp120; HIV; Photosensitizer; Polyanion; Porphyrin

Indexed keywords

AMINO ACID; ANION; ANTIBODY; CARBOXYL GROUP; DEUTEROPORPHYRIN DISULFONIC ACID; DEUTEROPORPHYRIN DISULFONIC ACID DIMETHYL ESTER; DEUTEROPORPHYRIN DISULFONIC ACID MONOMETHYL ESTER; DIMER; EPITOPE; GLYCOPROTEIN GP 120; HIV ENVELOPE PROTEIN GP120 (305 321); HIV ENVELOPE PROTEIN GP120 (305-321); HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOMER; PEPTIDE FRAGMENT; PHOTOSENSITIZING AGENT; PORPHYRIN; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CHEMISTRY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; ELECTRICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTERIFICATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INHIBITION KINETICS; IRRADIATION; LIGHT; MOLECULE; NONHUMAN; PHOTOACTIVATION; PHOTOREACTIVITY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN DOMAIN; SULFONATION;

EID: 0344253721     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00176-1     Document Type: Article

References (54)

1. Agatsuma T., Yamamoto I., Furukawa H., Nishigaki T. Guanine-rich oligonucleotide modified at the 5′ terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein. Antivir. Res. 31:1996;137-148.
2. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6132-6136.
3. Bensasson, R.V., Land, E.J., Truscott, T.G., 1993. Excited States and Free Radicals in Biology and Medicine: Contributions from Flash Photolysis and Pulse Radiolysis. Oxford University Press, Oxford, 442 pp.
4. Blair W.S., Lin P.F., Meanwell N.A., Wallace O.B. HIV-1 entry - an expanding portal for drug discovery. Drug Discov. Today. 5:2000;183-194.
5. Cantor, C.R., Schimmel, P.R., 1980. Biophysical Chemistry, Part II: Techniques for the Study of Biological Structure and Function. W. H. Freeman, San Francisco, 503 pp.
6. Coppey M., Jameson D.M., Alpert B. Oxygen diffusion through hemoglobin and HbdesFe: quenching of the tryptophan and porphyrin emissions. FEBS Lett. 126:1981;191-194.
7. Dairou J., Vever-Bizet C., Brault D. Self-association of disulfonated deuteroporphyrin and its esters in aqueous solution and photosensitized production of singlet oxygen by the dimers. Photochem. Photobiol. 75:2002;229-236.
8. Debnath A.K., Jiang S., Strick N., Lin K., Haberfield P., Neurath A.R. Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. J. Med. Chem. 37:1994;1099-1108.
9. De Clercq E. New developments in anti-HIV chemotherapy. Biochim. Biophys. Acta. 1587:2002;258-275.
10. Dodd R.Y., Notari E.P., Stramer S.L. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 42:2002;975-979.
11. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
12. Foote C.S. Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. Science. 162:1968;963-970.
13. Grandadam M., Ingrand D., Huraux J.M., Aveline B., Delgado O., Vever Bizet C., Brault D. Photodynamic inactivation of cell-free HIV strains by a red-absorbing chlorin-type photosensitizer. J. Photochem. Photobiol. B Biol. 31:1995;171-177.
14. Helseth E., Olshevsky U., Furman C., Sodroski J. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65:1991;2119-2123.
15. Jones P.L., Korte T., Blumenthal R. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273:1998;404-409.
16. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
17. Kwong P.D., Wyatt R., Sattentau Q.J., Sodroski J., Hendrickson W.A. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J. Virol. 74:2000;1961-1972.
18. Lopalco L., Longhi R., Ciccomascolo F., De Rossi A., Pelagi M., Andronico F., Moore J.P., Schulz T., Beretta A., Siccardi A.G. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies. AIDS Res. Hum. Retroviruses. 9:1993;33-39.
19. Maerz A.L., Drummer H.E., Wilson K.A., Poumbourios P. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association. J. Virol. 75:2001;6635-6644.
20. Margolis-Nunno H., Ben-Hur E., Gottlieb P., Robinson R., Oetjen J., Horowitz B. Inactivation by phthalocyanine photosensitization of multiple forms of human immunodeficiency virus in red cell concentrates. Transfusion. 36:1996;743-750.
21. Margolis-Nunno H., Bardossy L., Robinson R., Ben-Hur E., Horowitz B., Blajchman M.A. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo. Transfusion. 37:1997;889-895.
22. Matthews J.L., Sogandares-Bernal F., Judy M.M., Marengo-Rowe A.J., Leveson J.E., Skiles H., Newman J.T., Chanh T.C. Preliminary studies of photoinactivation of human immunodeficiency virus in blood. Transfusion. 31:1991;636-641.
23. Mitsuya H., Looney D.J., Kuno S., Ueno R., Wong-Staal F., Broder S. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science. 240:1988;646-649.
24. Moan J., Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53:1991;549-553.
25. Mohr H., Bachmann B., Klein-Struckmeier A., Lambrecht B. Virus inactivation of blood products by phenothiazine dyes and light. Photochem. Photobiol. 65:1997;441-445.
26. Moore J.P. Coreceptors: implications for HIV pathogenesis and therapy. Science. 276:1997;51-52.
27. Moore J.P., Sattentau Q.J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:1994;469-484.
28. Moore A., Herrera G., Nyamongo J., Lackritz E., Granade T., Nahlen B., Oloo A., Opondo G., Muga R., Janssen R. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet. 358:2001;657-660.
29. Moulard M., Lortat-Jacob H., Mondor I., Roca G., Wyatt R., Sodroski J., Zhao L., Olson W., Kwong P.D., Sattentau Q.J. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74:2000;1948-1960.
30. Neurath A.R., Haberfield P., Joshi B., Hewlett I.K., Strick N., Jiang S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. I. The V3 loop of gp120 as target. Antivir. Chem. Chemother. 2:1991;303-312.
31. Neurath A.R., Strick N., Haberfield P., Jiang S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. II. Porphyrins reacting with the V3 loop of gp120. Antivir. Chem. Chemother. 3:1992;55-63.
32. Neurath A.R., Strick N., Jiang S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. Approaches applicable to epidemic HIV-1 strains. Antivir. Chem. Chemother. 4:1993;207-214.
33. Neurath A.R., Strick N., Debnath A.K. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120. J. Mol. Recognit. 8:1995;345-357.
34. Niedre M., Patterson M.S., Wilson B.C. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol. 75:2002;382-391.
35. Nishimura S.I., Kai H., Shinada K., Yoshida T., Tokura S., Kurita K., Nakashima H., Yamamoto N., Uryu T. Regioselective syntheses of sulfated polysaccharides: specific anti-HIV-1 activity of novel chitin sulfates. Carbohydr. Res. 306:1998;427-433.
36. North J., Coombs R., Levy J. Photodynamic inactivation of free and cell-associated HIV-1 using the photosensitizer, benzoporphyrin derivative. J. Acquir. Immune Defic. Syndr. 7:1994;891-898.
37. Ostermann A., Waschipky R., Parak F.G., Nienhaus G.U. Ligand binding and conformational motions in myoglobin. Nature. 404:2000;205-208.
38. Papp S., King T.E., Vanderkooi J.M. Intrinsic tryptophan phosphorescence as a marker of conformation and oxygen diffusion in purified cytochrome oxidase. FEBS Lett. 283:1991;113-116.
39. Rapp F., Kemeny B.A. Oncogenic potential of herpes simplex virus in mammalian cells following photodynamic inactivation. Photochem. Photobiol. 25:1977;335-337.
40. Rizzuto C.D., Wyatt R., Hernández Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1998;1949-1953.
41. Schols D., Pauwels R., Desmyter J., De Clercq E. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology. 175:1990;556-561.
42. Siegel, S., Castellan, N.J., 1988. Nonparametric Statistics for Behavioral Sciences. Mc Graw-Hill, New-York, 399 pp.
43. Smith, K.C., 1989. The Science of Photobiology, 2nd ed. Plenum Publishing Corporation, New York, 466 pp.
44. Spikes, J.D., 1982. Photodynamic reactions in photomedicine. In: Regan, J.D., Parrish, J.A. (Eds.), The Science of Photomedicine. Plenum Press, New York, pp. 113-144.
45. Starcich B.R., Hahn B.H., Shaw G.M., McNeely P.D., Modrow S., Wolf H., Parks E.S., Parks W.P., Josephs S.F., Gallo R.C., Wong-Staal F. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell. 45:1986;637-648.
46. Stein C.A., Cleary A.M., Yakubov L., Lederman S. Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (V3) of human immunodeficiency virus type 1 gp120. Antisense Res. Dev. 3:1993;19-31.
47. Stephenson J. Researchers explore new anti-HIV agents. JAMA. 287:2002;1635-1637.
48. Sullivan N., Sun Y., Sattentau Q., Thali M., Wu D., Denisova G., Gershoni J., Robinson J., Moore J., Sodroski J. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:1998;4694-4703.
49. van Rhenen D., Gulliksson H., Cazenave J.P., Pamphilon D., Ljungman P., Kluter H., Vermeij H., Kappers-Klunne M., de Greef G., Laforet M., Lioure B., Davis K., Marblie S., Mayaudon V., Flament J., Conlan M., Lin L., Metzel P., Buchholz D., Corash L. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood. 101:2003;2426-2433.
50. Vever-Bizet C., Boutorine A.S., Delgado O., Brault D., Hélène C. Targeting of HIV gp120 by oligonucleotide- photosensitizer conjugates. Light-induced damages. FEBS Lett. 462:1999;467-471.
51. Witvrouw M., Desmyter J., De Clercq E. Antiviral portrait series: 4. Polysulfates as inhibitors of HIV and other enveloped viruses. Antivir. Chem. Chemother. 5:1994;345-359.
52. Wu H., Kwong P.D., Hendrickson W.A. Dimeric association and segmental variability in the structure of human CD4. Nature. 387:1997;527-530.
53. Wyatt J.R., Vickers T.A., Roberson J.L., Buckheit R.W., Klimkait T., Debaets E., Davis P.W., Rayners B., Imbach J.L., Eckers D.J. Combinatorially selected guanine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1356-1360.
54. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711.